Table 5.

Prolactinoma patients who developed Hypersexuality while on Dopamine Agonist therapy

N	Age, years	Sex, M/F	Tumour size (last MRI), mm	DA, weekly dose in mg	Comment
1	66	M	12	Cabergoline, 1 mg	Extreme symptomatology, leading to loss of job, divorce, promiscuity.
2	33	M	8	Cabergoline, 0.5 mg	Could not be reached
3	43	F	5	Cabergoline, 0.5 mg	Symptoms resolved after cabergoline was stopped by endocrinologist
4	46	F	5	Cabergoline, 0.5 mg	Symptoms not interfering with life
5*	60	M	32	Cabergoline, 1 mg	Patient recalls that symptoms improved with lowering the cabergoline dose.
6	38	M	21	Bromocriptine, 52.5mg	Symptoms improved with dose reduction to 35 mg weekly. Dose further decreased during follow up visit to 17.5 mg weekly
7	39	M	0	Cabergoline, does not recall the dose	Symptoms resolved after cabergoline was stopped due to curative pituitary surgery
8	47	M	3	Cabergoline,0.5mg	Symptoms not interfering with life
9	66	M	3	Cabergoline, 2 mg	Symptoms not interfering with life, dose decreased by provider
10	53	F	2	Bromocriptine, 35 mg	Symptoms resolved after bromocriptine was stopped by endocrinologist

^*patient with panhypopituitairism